Public Policy

Healthcare Labor Law Issues Intensify for 2026
Public Policy Healthcare Labor Law Issues Intensify for 2026

The legal framework governing healthcare employment has become a labyrinth of unprecedented complexity, where the convergence of technological disruption, persistent staffing shortages, and aggressive regulatory oversight now defines the operational reality for every provider. The pressures that

How Did a Colombian Hospital Master Digital Health?
Public Policy How Did a Colombian Hospital Master Digital Health?

In the complex world of global healthcare, a Colombian institution has quietly emerged as a formidable leader, demonstrating that world-class digital innovation is not confined to the usual economic powerhouses. The International Hospital of Colombia (HIC) has not only achieved but also sustained

How Will the Great Healthcare Plan Affect Employers?
Public Policy How Will the Great Healthcare Plan Affect Employers?

The persistent upward spiral of healthcare expenditures has long been a defining challenge for American businesses, shaping everything from hiring decisions to long-term financial strategy. The recent unveiling of the proposed Great Healthcare Plan on January 15, 2026, represents a significant

What’s Fueling the Healthcare Affordability Crisis?
Public Policy What’s Fueling the Healthcare Affordability Crisis?

Following an extensive nine-hour congressional session with top health insurance executives, it has become undeniably clear that the American healthcare affordability crisis is a systemic issue demanding a comprehensive, system-wide resolution. The labyrinth of rising premiums, staggering

RFK Jr. Backs Unproven Stem Cell Cures Amid Patient Harm
Public Policy RFK Jr. Backs Unproven Stem Cell Cures Amid Patient Harm

A powerful narrative of medical innovation and personal autonomy is colliding with the devastating reality of patient harm, creating a high-stakes battle over the future of experimental medicine in the United States. At the center of this conflict is the burgeoning, largely unregulated market for

New Medicare Drug Negotiations Pose Little Threat to Pharma
Public Policy New Medicare Drug Negotiations Pose Little Threat to Pharma

Despite the federal government's high-profile initiative aimed at reining in prescription drug costs, a detailed financial analysis of the latest round of Medicare negotiations suggests the direct monetary impact on pharmaceutical giants will be surprisingly modest. The Centers for Medicare

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later